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1. Introduction 
Skin is the largest organ in humans and protects the body from environmental factors. The 
dermis is a layer that acts to protect the body from external physical force. Viscoelasticity is 
essential to facilitate the physical function of the skin. However, the clinical-biological-physical 
relevance of dermal connective tissue has not been fully investigated. In this chapter, we 
review past studies in this vast field and attempt to elucidate the combined clinical-biological-
physical relevance of dermal connective tissue. In addition, we discuss Tarumi disease, which 
is characterized by impaired viscoelasticity and stiffness in connective tissues. 
2. Extracellular matrices contribute to the viscoelastic properties of 
connective tissues including the dermis 
The viscoelastic properties of human tissues are principally governed by the nature of the 
extracellular matrix (ECM). The ECM comprises secreted proteins that are deposited into the 
extracellular space. Although cell-ECM interaction and growth factor-ECM interactions 
have recently been investigated, the ECM represents the fundamental architecture of tissue. 
Some ECM proteins supply the connective tissues with hydration and resiliency through 
their characteristic molecular properties and assembly. ECM proteins such as collagen, 
proteoglycans, and glycoproteins are classified by their biochemical properties rather than 
their physical properties. Numerous ECM proteins are currently known and have been well 
characterized biologically. However, the contribution of each ECM protein to the 
viscoelastic properties of tissues has not been fully investigated due to the lack of a proper 
experimental system. Therefore, the contribution of each ECM protein to viscoelasticity in 
human tissue should be determined based on biological, physical, and clinical studies.  
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3. Connective tissue elements in the dermis: Collagen fiber, elastic fiber, 
and ground substance 
As the dermis is the layer that protects the body from physical stress, understanding the 
nature of dermal connective tissues is vital. In this section, 3 components of connective 
tissues and the ECM are briefly introduced. ECM molecules are produced primarily by 
fibroblast cells. 
Collagen fibers are major elements of the dermis and collagens are the most abundant 
protein in the human body; the dermis alone is composed of approximately 75% collagen 
proteins in dry weight. Twenty-eight collagen species have presently been identified. It has 
been reported that skin contains collagen types I, III, IV-VII, XIII, and XIV, with the major 
collagen in the dermis being type I collagen. Collagens that associate with the type I collagen 
fiber are classified as FACIT collagens and can provide additional mechanical properties to 
tissues. Collagens are characterized by repeated glycine-X-Y sequences and form triple-
helical structures that are extensively modified after their secretion into the extracellular 
space. In immature tissues, such as those found in wound healing and fibrosis, type III 
collagen is expressed; however, it is not yet strong enough to support mature connective 
tissues. As the wound matures, type I collagen becomes dominant. Heterotypic type I and 
type III collagen fibrils are present in the dermis. Type VI collagen individually forms a 
unique filament called a microfilament (1,2).  
Elastic fiber comprises elastin and microfibrils. As the dermis has to be stretched to adapt to 
the movement of body parts, elasticity is a critical property of the dermis. Elastin—a unique 
molecule that stretches and shrinks—is secreted as tropoelastin (the soluble precursor of 
mature elastin) and is subsequently processed and cross-linked within the extracellular 
space. Cross-linking by lysyl oxidase and desmosine formation is a crucial step for the 
stabilization of elastin within tissues. Another element in elastic fibers is fibrillin-microfibril. 
Microfibrils are fibrous elements that are 10 nm in width and are comprised mainly of 
fibrillins. Fibrillin is a large glycoprotein that is rich in cysteine residues and homotypically 
assembles into a microfibril in a well-regulated manner (3, 4). Fibrillins align in a parallel 
manner, from head to tail, in a staggered fashion within extracellular microfibrils (5). Other 
ECM molecules, including microfibril-associated glycoproteins (MAGPs), latent TGF-beta 
binding proteins (LTBPs), type XVI collagen, emilin, and versican, can associate with 
microfibrils through their binding affinity with fibrillins. Fibulins are yet another elastic 
fiber component, which can bridge elastin and microfibrils by their binding properties. 
Interestingly, fibulin-5 knock-out mice exhibit skin looseness (6, 7), indicating that this 
molecule may be essential for the development of elastic tissue. 
Thick elastic fiber distributes horizontally in the reticular dermis, whereas thinner elastic 
fiber, including elaunin and oxytalan fibers, are seen to distribute in the papillary dermis. 
Oxytalan fibers are formed by bundled microfibrils without amorphous elastin. The staining 
of fibrillin in the skin shows horizontal distribution in the reticular dermis and vertical 
orientation in the papillary dermis (Figure 1). This complex elastic fiber meshwork confers 
the dermis with the ideal viscoelasticity to effectively protect the human body.  
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Figure 1. Immunohistochemical staining of fibrillin-1 in the human dermis. The distinct alignment of 
elastic fiber elements differs between the layers of the dermis 
Proteoglycans are glycosaminoglycans (GAGs) that are covalently linked to a core protein. 
GAGs can be chondrotin/dermatan sulfate, heparan sulfate, heparin, and hyaluronan. GAGs 
hold a large amount of water within connective tissue, whereas free water in connective 
tissue is observed as edema. In particular, hyaluronan (HA) has a high affinity to water 
through its charge and, in general, is a high molecular weight linear GAG that distributes 
ubiquitously in connective tissue. Proteoglycans are major components of ground substance 
and are occasionally associated with fiber components in the dermis. Therefore, GAG is 
essential for maintaining the tissue viscosity of dermal connective tissue. In dermal 
connective tissues, decorin and versican are the major proteoglycans (8). Decorin is a small 
dermatan sulfate proteoglycan that binds to type I collagen. In the dermis, decorin is 
abundant in the papillary and the reticular dermis. Scott et al. have proposed that, through 
their charge, GAG chains of decorin can play a role in the viscoelastic property of connective 
tissue (9, 10). These models highlight the importance of GAG chains to the viscoelastic 
properties of connective tissues.  
The supramolecular organization of the ECM in the dermis has been investigated using 
biochemical, biophysical, and ultrastructural methods. Connective tissues are not 
composed of a simple mixture of ECM molecules; therefore, the manner in which the 
ECM molecules assemble into fibrous components should be further investigated (11). In 
the dermis, each ECM molecule assembles into either elastic fiberous elements or ground 
substance. This can be observed in the electron micrograph of dermal connective tissue 
shown in Figure 2. Collagen and elastic fiber distribute distinctly, whereas the “empty 
space” is believed to be filled by ground substance. Thus, collagen and elastic fiber is 
embedded within ground substance, which itself is comprised of proteoglycans and 
hyaluronan. 
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Figure 2. Electron microscopic image of dermal connective tissues. Col: collagen fiber, El: elastin core, 
MF: microfibrils (Bar = 200 nm) 
4. Versican is a chondroitin sulfate proteoglycan and is critical for dermal 
viscoelasticity 
Among the ECM molecules in the dermis, versican appears to be the most important molecule 
for tissue viscoelasticity. Versican (also called PG-M) is a large chondroitin sulfate 
proteoglycan that was originally characterized in a mesenchymal condensation in chick limb 
bud (12). Versican binds to hyaluronan via its amino-terminal G1 domain and to fibrillin-1, 
fibulin-1 and fibulin-2 via its carboxyl terminal G3 domain. The distribution of versican is 
similar to that of elastic fiber in the dermis and in other tissues (13, 14) and is immunolocalized 
to microfibrils through its binding affinity to fibrillin-1 (15) as observed in Figure 3. 
Thus, versican plays critical roles in the viscoelastic properties of skin. Versican 1) connects 
with elastic microfibrils by binding to fibrillin via its G3 domain; 2) has chondroitin sulfate 
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chains that hold a large amount of water within the ECM space; and 3) binds to HA, which 
holds a large quantity of water. Figure 4 shows the proposed structural model of the elastic-
hydrated matrix in the dermis. Furthermore, the fibrillin-versican-hyaluronan network is 
also observed in the ciliary body (16). 
 
Figure 3. Versican co-localizes with fibrillin-1 in the dermis. Immunofluorescent staining using specific 
antibodies against versican and fibrillin-1 show co-localization. 
 
Figure 4. Schematic presentation of the dermal viscoelastic network linked by versican. Versican links 
elastic fibers to ground substance. 
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5. Biophysical examination of the skin and subcutaneous tissues 
The fundamental role of human skin is to protect the body from invasion by external factors. 
Biological and chemical invasions of the body could be prevented by the skin, which include 
circulating cells of the innate immune system. Furthermore, protection from physical 
invasions—such as mechanical force and thermo injuries—are also important to maintain 
the homeostasis of the human body.  
Skin consists of 3 layers, which include the epidermis, dermis, and subcutaneous tissue. Skin 
covers most of the body’s surface, except for some “holes such as oral cavity”. Thus, the physical 
barrier that skin provides is crucial to protect the human musculoskeletal system and internal 
organs. The physical properties of skin have been measured using several devices (17). In this 
study, the authors measured the mechanical properties of the skin by dynamic indentation. This 
study noted that the measurement of these mechanical properties by indentation is not well 
correlated with that by suction. (17). Furthermore, they also reported the aging-associated 
alteration of mechanical properties of the skin (18). The CutemeterTM has been used to measure 
the viscoelasticity of skin. Additionally, we have recently established a novel method to measure 
the viscoelasticity of skin using a rheometer (AR instrument, AR 550) (Figure 5).  
 
Figure 5. A rheometer can be used to determine the viscoelasticity of skin.  
Using this method, skin is treated as a complex of different materials. The skin surface at the 
bottom of an appendage is immobilized so that deformity is only obtained by the external 
force generated from the upper probe. From the results shown in Figure 6, viscoelasticity of 
skin (and subcutaneous tissues) was estimated to be approximately 30 kPa. This data was 
not influenced by muscle contraction, thus indicating that the origin of the physical 
properties of skin could be the fascia (19).  
Next, we developed a physical model for pressure ulcers and mechanical force around the 
ulcer was measured using our new device, real time skin strain monitor (RTSSM). A 
pressure ulcer is characterized as a skin and soft tissue injury caused by an external force on 
a bony prominence. However, it is not clear how a pressure ulcer is strained by external 
force. Previous studies have reported the similarity in strain properties of human soft tissue 
and industrial buffer materials. Therefore, we utilized a cell sponge as a testing material for 
its physically similar attributes to soft tissues. As shown in Figure 7, a physical model for 
pressure ulcers was developed. Strain gauge probes were stitched around the pressure ulcer 
model as indicated. 
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Figure 6. Viscoelasticity measurement by muscle contraction. 
 
Figure 7. The composition of a pressure ulcer model and the positions of strain gauge probes. The 
physical model for the pressure ulcer is made of sponges; the probes are placed around the hole 
mimicking pressure ulcer. 
Figure 8 shows the data observed from RTSSM when a tensile load is applied toward the 
channel 2–4 direction. From the results, it can be observed that this method is able to 
measure the strain force during the loaded state (0–0.3 seconds) and the relaxed state (after 
0.3 seconds). 
We further examined our model by testing the strain force around a pressure ulcer in a 
patient. This study was approved by the ethics committee of our institution and performed 
following written informed consent was obtained from the patients. As shown in Figure 9, 
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the probe was adhered onto the dressing and the strained force was measured in the 
bedridden patients.  
 
Figure 8. RTSSM measured by the strain distribution of a pressure ulcer model. The loading force is 
increased by 100 μ strain/s from the initial load at 50 μ strain/s and a maximum force of 250 μ strain/s is 
maintained.  
 
Figure 9. Measurement of strain force around pressure ulcers. 
It has been noted that the head lifting position of the patient can occasionally worsen a 
pressure ulcer. Therefore, the manner in which positioning changes influence a pressure 
ulcer is an important issue for the care of a patient. To address this issue, we measured 
strain forces around the pressure ulcer during positioning changes. Measurement using 
RTSSM indicates that a positioning change can generate a strain force around the wound 
(Figure 10).  
Point A 
(Right) 
Point B 
(Left) 
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Figure 10. Changes in strain force at the buttocks are dependent on a positional change in head lifting. 
Using the RTSSM, we next determined the direction of force by coordinating data from 
several probes. To this end, multiple probes can be adhered around the wound (Figure 11) 
and the measured force can be generated. In this case, it was reasoned that the different 
vectors, representing the strain force between the right and left sides, were generated due to 
the contracture of the right leg. Thus, the data obtained can be used to determine the 
positioning change that is ideal in the care of the patient with a pressure ulcer (20).  
 
Figure 11. Positioning changes generate strain force on a pressure ulcer toward a specific direction. 
When the position of head is lifted at the indicated degree (15 or 30) a strain force is promptly changed.  
15deg. 15deg. 15deg. 15deg. 
30deg. 30deg. 0deg. 
15 degree 
Point B 
(Left) 
Point A 
(Right) 
30 degree 
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6. Diseases caused by impaired viscoelastic properties of connective 
tissues 
We discuss aging-associated diseases that result in impaired physical properties of 
connective tissues based on a review of genetic diseases that cause impairment in the 
physical properties of connective tissues.  
Marfan syndrome (MFS) is a relatively common genetic connective tissue disease. MFS is an 
autosomal dominant connective tissue disease that affects the aorta, lungs, ciliary zonule, 
muscles, and other organs. However, most phenotypes appear only in the later stages of life. 
The primary cause of MFS appears to be due to mutations in the microfibrillar molecule 
fibrillin-1, although some phenotypes observed in various organs are believed to develop 
from the dysregulation of TGF-beta. One explanation for the genotype-phenotype 
correlation is due to the aberrant activation of TGF-beta stored within microfibrils through 
the binding between fibrillin-1 and LTBPs (21) (Figure 4). Recent studies have highlighted 
the importance of proper modulation of non-canonical TGF-beta signaling (22). The role of 
versican in MFS is currently unknown. Interestingly, the tissue phenotype resulting from 
MFS shows similarities to that of aging. For instance, aneurysm, emphysema, hernia, and 
muscle atrophy are all common features of MFS patients and also of elderly patients. 
However, the correlation between MFS and aging connective tissue phenotypes is currently 
unknown. MFS appears to be a model for impaired viscoelasticity of human tissues, which 
is discussed in the following section.  
7. Aging-dependent changes of versican in the dermal connective tissues 
The dermis changes prominently with age; for example, the thickness of the dermis becomes 
thin and wrinkles appear. Biochemical collagen content and histological density of collagen 
fiber is reduced (23). We have shown that versican is a key molecule for viscoelasticity of the 
dermis. The amount of versican extracted from the dermis decreases with age and its GAG 
composition is also altered (24, 25). Therefore, as described above, we hypothesize that loss 
or reduction of versican, or in the HA binding ability of versican, may lead to impaired 
viscoelasticity of the dermis. Versican is heavily accumulated within solar elastosis, which is 
a hallmark of photo-aged skin and where elastic fiber components, including elastin and 
fibrillin-1, have accumulated (26). Clinically, photo-aged skin is not viscoelastic and shows 
deep wrinkles, as observed in Figure 12.  
Using recombinant versican G1 proteins and specific antibodies, we have indicated that a 
loss in the HA binding affinity of versican is characteristically observed in the region of solar 
elastosis (27). Versican specifically loses its HA binding domain (6084) in solar elastosis, 
whereas the carboxyl terminal domain (2B1) remains present. Therefore, the HA binding 
ability of elastic fibers is lost and microfibrils in solar elastosis are unable to bind to HA 
(Figure 13). Therefore, loss of the HA binding region of versican disrupts the fibrillin-
versican-hyaluronan (Fi-Ver-Hy) network in the dermis. 
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Figure 12. Clinical appearance of photo-aged skin. Deep wrinkles and comedo (black dots) are observed. 
 
Figure 13. Histochemical results of solar elastosis. Versican is detected by its anti-fibrillin binding 
region (2B1) or its anti-HA binding region (6084). HA is detected using a biotin-conjugated link protein 
(biotin LP). 
8. Tarumi disease 
Based on the physical properties of skin and other connective tissues, we propose “Tarumi 
disease” as an aging-associated, connective tissue loosening disease. Tarumi diseases are 
preferentially found in the elderly population, with some exceptions. Tarumi is a Japanese 
word that represents tissue loosening. Aging-associated loosening of connective tissue is a 
major pathogenesis for emphysema, aneurysm, skin wrinkles, pelvic organ, and hernias. 
The Tarumi diseases that we are proposing are listed in the table below (Table 1). In 2001, an 
interesting association between pseudoexfoliation syndrome and abdominal aortic 
aneurysm was reported (28). However, it should be noted that this report has not been 
supported by the subsequent studies on the prevalence of these conditions.  
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Common pathogenesis among each Tarumi disease is currently unclear. Smoking is 
considered to be a precipitating factor in the common pathogenesis of aortic aneurysm and 
chronic obstructive pulmonary disease (COPD) (29, 30). However, other factors should be 
investigated for the Tarumi diseases. Tarumi disease may provide a novel perspective of 
tissue aging in geriatrics. 
Therefore, studying Tarumi disease may be a useful step toward understanding common 
pathogenesis among these diseases. Future directions in Tarumi disease research require 
pathological, biochemical, and physical studies. Methods presented in this chapter may 
evaluate the looseness of tissues. Furthermore, surgical intervention using a tissue filler may 
be a useful method to improve these diseases. Finally, the phenotypical relationship 
between MFS and Tarumi disease may lead to understanding their common pathogenesis. 
 
Organ Proposed diseases
Aorta Aortic aneurysm 
Lung  Chronic obstructive pulmonary disease 
Pelvis Pelvis organ prolapse 
Vein Varicose vein 
Skin  Wrinkles, Pressure ulcer 
Abdomen  Hernia 
Esophagus Esophageal hiatal hernia 
Table 1. Proposed Tarumi diseases.  
9. Conclusion 
Viscoelastic properties of the skin can be measured by various methods and are dependent on 
the connective tissue architecture formed by ECM molecules. In order to measure the actual 
viscoelasticity of the skin, we have developed a novel device that can monitor the external 
forces on the skin in real time. The device can be used for treatment and prevention of pressure 
ulcers that are affected by viscoelasticity and external force. Among the ECM molecules, 
versican—a chondroitin sulfate proteoglycan—is an important ECM molecule for 
viscoelasticity because it constitutes the fibrillin-versican-hyaluronan network. In human 
pathogenic conditions such as solar elastosis, loss of viscoelastic properties of the dermis is 
found to occur because of the loss of hyaluronan-binding versican. Marfan syndrome—a 
genetic connective tissue disease—is also characterized by loss of viscoelasticity in elastic 
tissues, such as those in the aorta. Finally, aging-associated loss of viscoelasticity and stiffness 
of connective tissue are proposed to be the common pathogenesis of Tarumi disease.  
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